CompuGroup Medical SE & Co. KGaA

XTRA:COP 株式レポート

時価総額:€1.2b

CompuGroup Medical SE KGaA マネジメント

マネジメント 基準チェック /24

CompuGroup Medical SE KGaAの CEO はDaniel Gotthardtで、 Sep2024年に任命され、 の在任期間は 1 年未満です。 は、会社の株式の6.66%を直接所有しており、その価値は€ 81.38M 。経営陣と取締役会の平均在任期間はそれぞれ2.3年と4.1年です。

主要情報

Daniel Gotthardt

最高経営責任者

n/a

報酬総額

CEO給与比率n/a
CEO在任期間less than a year
CEOの所有権6.7%
経営陣の平均在職期間2.3yrs
取締役会の平均在任期間4.1yrs

経営陣の近況

Recent updates

Is It Too Late To Consider Buying CompuGroup Medical SE & Co. KGaA (ETR:COP)?

Nov 26
Is It Too Late To Consider Buying CompuGroup Medical SE & Co. KGaA (ETR:COP)?

CompuGroup Medical SE & Co. KGaA's (ETR:COP) Popularity With Investors Is Clear

Nov 08
CompuGroup Medical SE & Co. KGaA's (ETR:COP) Popularity With Investors Is Clear

Here's What's Concerning About CompuGroup Medical SE KGaA's (ETR:COP) Returns On Capital

Sep 06
Here's What's Concerning About CompuGroup Medical SE KGaA's (ETR:COP) Returns On Capital

Here's Why CompuGroup Medical SE KGaA (ETR:COP) Has A Meaningful Debt Burden

Aug 20
Here's Why CompuGroup Medical SE KGaA (ETR:COP) Has A Meaningful Debt Burden

What You Can Learn From CompuGroup Medical SE & Co. KGaA's (ETR:COP) P/E After Its 34% Share Price Crash

Aug 04
What You Can Learn From CompuGroup Medical SE & Co. KGaA's (ETR:COP) P/E After Its 34% Share Price Crash

CompuGroup Medical SE & Co. KGaA (ETR:COP) Just Reported Earnings, And Analysts Cut Their Target Price

Jul 18
CompuGroup Medical SE & Co. KGaA (ETR:COP) Just Reported Earnings, And Analysts Cut Their Target Price

Is It Too Late To Consider Buying CompuGroup Medical SE & Co. KGaA (ETR:COP)?

Jul 15
Is It Too Late To Consider Buying CompuGroup Medical SE & Co. KGaA (ETR:COP)?

Investors Still Waiting For A Pull Back In CompuGroup Medical SE & Co. KGaA (ETR:COP)

Jun 11
Investors Still Waiting For A Pull Back In CompuGroup Medical SE & Co. KGaA (ETR:COP)

The Returns On Capital At CompuGroup Medical SE KGaA (ETR:COP) Don't Inspire Confidence

May 24
The Returns On Capital At CompuGroup Medical SE KGaA (ETR:COP) Don't Inspire Confidence

Earnings Release: Here's Why Analysts Cut Their CompuGroup Medical SE & Co. KGaA (ETR:COP) Price Target To €43.20

May 11
Earnings Release: Here's Why Analysts Cut Their CompuGroup Medical SE & Co. KGaA (ETR:COP) Price Target To €43.20

CompuGroup Medical SE KGaA (ETR:COP) Will Pay A Larger Dividend Than Last Year At €1.00

Apr 27
CompuGroup Medical SE KGaA (ETR:COP) Will Pay A Larger Dividend Than Last Year At €1.00

CompuGroup Medical SE KGaA's (ETR:COP) Upcoming Dividend Will Be Larger Than Last Year's

Apr 12
CompuGroup Medical SE KGaA's (ETR:COP) Upcoming Dividend Will Be Larger Than Last Year's

We Think CompuGroup Medical SE KGaA (ETR:COP) Can Stay On Top Of Its Debt

Mar 20
We Think CompuGroup Medical SE KGaA (ETR:COP) Can Stay On Top Of Its Debt

CompuGroup Medical SE & Co. KGaA (ETR:COP) Shares Could Be 49% Below Their Intrinsic Value Estimate

Feb 08
CompuGroup Medical SE & Co. KGaA (ETR:COP) Shares Could Be 49% Below Their Intrinsic Value Estimate

Investors Interested In CompuGroup Medical SE & Co. KGaA's (ETR:COP) Earnings

Jan 25
Investors Interested In CompuGroup Medical SE & Co. KGaA's (ETR:COP) Earnings

Is It Time To Consider Buying CompuGroup Medical SE & Co. KGaA (ETR:COP)?

Jan 12
Is It Time To Consider Buying CompuGroup Medical SE & Co. KGaA (ETR:COP)?

The Returns On Capital At CompuGroup Medical SE KGaA (ETR:COP) Don't Inspire Confidence

Dec 28
The Returns On Capital At CompuGroup Medical SE KGaA (ETR:COP) Don't Inspire Confidence

We Think CompuGroup Medical SE KGaA (ETR:COP) Can Stay On Top Of Its Debt

Dec 15
We Think CompuGroup Medical SE KGaA (ETR:COP) Can Stay On Top Of Its Debt

Is CompuGroup Medical SE & Co. KGaA (ETR:COP) Potentially Undervalued?

Oct 09
Is CompuGroup Medical SE & Co. KGaA (ETR:COP) Potentially Undervalued?

CompuGroup Medical SE KGaA (ETR:COP) Could Be Struggling To Allocate Capital

Sep 22
CompuGroup Medical SE KGaA (ETR:COP) Could Be Struggling To Allocate Capital

Do CompuGroup Medical SE KGaA's (ETR:COP) Earnings Warrant Your Attention?

Sep 07
Do CompuGroup Medical SE KGaA's (ETR:COP) Earnings Warrant Your Attention?

Is CompuGroup Medical SE & Co. KGaA (ETR:COP) Trading At A 33% Discount?

Aug 23
Is CompuGroup Medical SE & Co. KGaA (ETR:COP) Trading At A 33% Discount?

Here's Why CompuGroup Medical SE KGaA (ETR:COP) Can Manage Its Debt Responsibly

Jul 13
Here's Why CompuGroup Medical SE KGaA (ETR:COP) Can Manage Its Debt Responsibly

At €46.82, Is CompuGroup Medical SE & Co. KGaA (ETR:COP) Worth Looking At Closely?

Jun 24
At €46.82, Is CompuGroup Medical SE & Co. KGaA (ETR:COP) Worth Looking At Closely?

CompuGroup Medical SE KGaA (ETR:COP) Is Reinvesting At Lower Rates Of Return

May 27
CompuGroup Medical SE KGaA (ETR:COP) Is Reinvesting At Lower Rates Of Return

CompuGroup Medical SE KGaA (ETR:COP) Has Announced A Dividend Of €0.50

May 11
CompuGroup Medical SE KGaA (ETR:COP) Has Announced A Dividend Of €0.50

Is CompuGroup Medical SE & Co. KGaA (ETR:COP) Trading At A 32% Discount?

May 06
Is CompuGroup Medical SE & Co. KGaA (ETR:COP) Trading At A 32% Discount?

We Think CompuGroup Medical SE KGaA (ETR:COP) Can Stay On Top Of Its Debt

Apr 06
We Think CompuGroup Medical SE KGaA (ETR:COP) Can Stay On Top Of Its Debt

What Does CompuGroup Medical SE & Co. KGaA's (ETR:COP) Share Price Indicate?

Mar 07
What Does CompuGroup Medical SE & Co. KGaA's (ETR:COP) Share Price Indicate?

Be Wary Of CompuGroup Medical SE KGaA (ETR:COP) And Its Returns On Capital

Feb 06
Be Wary Of CompuGroup Medical SE KGaA (ETR:COP) And Its Returns On Capital

An Intrinsic Calculation For CompuGroup Medical SE & Co. KGaA (ETR:COP) Suggests It's 28% Undervalued

Jan 21
An Intrinsic Calculation For CompuGroup Medical SE & Co. KGaA (ETR:COP) Suggests It's 28% Undervalued

These 4 Measures Indicate That CompuGroup Medical SE KGaA (ETR:COP) Is Using Debt Reasonably Well

Jan 05
These 4 Measures Indicate That CompuGroup Medical SE KGaA (ETR:COP) Is Using Debt Reasonably Well

Is Now An Opportune Moment To Examine CompuGroup Medical SE & Co. KGaA (ETR:COP)?

Dec 06
Is Now An Opportune Moment To Examine CompuGroup Medical SE & Co. KGaA (ETR:COP)?

CEO(最高経営責任者

Daniel Gotthardt (51 yo)

less than a year

在職期間

€60,000

報酬

Dr. Daniel Gotthardt is MD & CEO of CompuGroup Medical SE & Co. KGaA since September 1, 2024 and had been its Chief Medical Officer since 2023 until September 2024 and was its Senior Vice President from 20...


リーダーシップ・チーム

名称ポジション在職期間報酬所有権
Hannes Reichl
MD of Impatient & Social Care and Member of the Management Board6.3yrs€1.77m0.0074%
€ 90.9k
Emanuele Mugnani
MD of Ambulatory Information Systems Europe & Member of Management Board3.3yrs€690.00k0.0013%
€ 15.9k
Ulrich Thome
MD of Ambulatory Information Systems DACH & Member of the Management Board1.3yrs€2.40m0.00055%
€ 6.7k
Daniel Gotthardt
MD & CEOless than a year€60.00k6.66%
€ 81.4m
Daniela Hommel
MD, CFO & Member of Management Board1yrデータなしデータなし
Claudia Thomé
Corporate Vice President of Investor Relationsno dataデータなしデータなし
Helge Weiß
Senior Vice President of Connectivity5yrsデータなしデータなし

2.3yrs

平均在職期間

50.5yo

平均年齢

経験豊富な経営陣: COPの経営陣は 経験豊富 であると考えられます ( 2.3年の平均在職年数)。


取締役

名称ポジション在職期間報酬所有権
Philipp von Ilberg
Chairman of Supervisory Board4.7yrs€100.00kデータなし
Dierk Heimann
Member of Medical Advisory Boardno dataデータなしデータなし
Ulrike Handel
Independent Member of Supervisory Board4.7yrs€48.00kデータなし
Bettina Volkens
Member of Supervisory Board4.7yrs€40.00kデータなし
Matthias Stormer
Member of Supervisory Board4.7yrs€60.00k0.0024%
€ 29.6k
Martin Kohrmann
Member of Supervisory Board4.7yrs€40.00k0.015%
€ 181.9k
Ayfer Basal
Employee Representative Member of Supervisory Board3.4yrs€50.00kデータなし
Adelheid Hegemann
Employee Representative Member of Supervisory Board3.4yrs€40.00k0.000060%
€ 733.2
Frank Betz
Employee Representative Member of Supervisory Board3.4yrs€50.00kデータなし
Stefan Weinmann
Vice Chairman of the Supervisory Board3.4yrs€60.00k0.000050%
€ 611.0
Julia Mole
Employee Representative Member of Supervisory Board4.1yrs€40.00kデータなし
Reinhard Lyhs
Member of Supervisory Board1.9yrs€34.00k0.00037%
€ 4.5k

4.1yrs

平均在職期間

57yo

平均年齢

経験豊富なボード: COPの 取締役会経験豊富 であると考えられます ( 4.1年の平均在任期間)。


企業分析と財務データの現状

データ最終更新日(UTC時間)
企業分析2025/02/15 16:50
終値2025/02/14 00:00
収益2024/09/30
年間収益2023/12/31

データソース

企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。

パッケージデータタイムフレーム米国ソース例
会社財務10年
  • 損益計算書
  • キャッシュ・フロー計算書
  • 貸借対照表
アナリストのコンセンサス予想+プラス3年
  • 予想財務
  • アナリストの目標株価
市場価格30年
  • 株価
  • 配当、分割、措置
所有権10年
  • トップ株主
  • インサイダー取引
マネジメント10年
  • リーダーシップ・チーム
  • 取締役会
主な進展10年
  • 会社からのお知らせ

* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用

特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM(Trailing Twelve Month)またはLTM(Last Twelve Month)データとして知られています。詳細はこちら

分析モデルとスノーフレーク

このレポートの作成に使用した分析モデルの詳細は、Githubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeでのチュートリアルもご用意しています。

シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。

業界およびセクターの指標

私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。

アナリスト筋

CompuGroup Medical SE & Co. KGaA 9 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。17

アナリスト機関
Knut WollerBaader Helvea Equity Research
Gerhard SchwarzBaader Helvea Equity Research
Gunnar CohrsBerenberg